Syndax Pharmaceuticals (SNDX) Tops Q1 EPS by 17c

Syndax Pharmaceuticals (NASDAQ: SNDX) reported Q1 EPS of ($0.79), $0.17 better than the analyst estimate of ($0.96).

For earnings history and earnings-related data on Syndax Pharmaceuticals (SNDX) click here.

You May Also Be Interested In

• BJ's Wholesale Club (BJ) Tops Q2 EPS by 19c, Beats on Revenue; Offers FY27 EPS Guidance
• ATRenew Inc (RERE) Tops Q2 EPS by 8c ; Offers Guidance
• Bill.com (BILL) Tops Q4 EPS by 14c, Beats on Revenue; Offers FY27 Guidance